1
|
Francis EC, Powe CE, Lowe WL, White SL, Scholtens DM, Yang J, Zhu Y, Zhang C, Hivert MF, Kwak SH, Sweeting A. Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis. COMMUNICATIONS MEDICINE 2023; 3:185. [PMID: 38110524 PMCID: PMC10728189 DOI: 10.1038/s43856-023-00393-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Accepted: 10/25/2023] [Indexed: 12/20/2023] Open
Abstract
BACKGROUND Perinatal outcomes vary for women with gestational diabetes mellitus (GDM). The precise factors beyond glycemic status that may refine GDM diagnosis remain unclear. We conducted a systematic review and meta-analysis of potential precision markers for GDM. METHODS Systematic literature searches were performed in PubMed and EMBASE from inception to March 2022 for studies comparing perinatal outcomes among women with GDM. We searched for precision markers in the following categories: maternal anthropometrics, clinical/sociocultural factors, non-glycemic biochemical markers, genetics/genomics or other -omics, and fetal biometry. We conducted post-hoc meta-analyses of a subset of studies with data on the association of maternal body mass index (BMI, kg/m2) with offspring macrosomia or large-for-gestational age (LGA). RESULTS A total of 5905 titles/abstracts were screened, 775 full-texts reviewed, and 137 studies synthesized. Maternal anthropometrics were the most frequent risk marker. Meta-analysis demonstrated that women with GDM and overweight/obesity vs. GDM with normal range BMI are at higher risk of offspring macrosomia (13 studies [n = 28,763]; odds ratio [OR] 2.65; 95% Confidence Interval [CI] 1.91, 3.68), and LGA (10 studies [n = 20,070]; OR 2.23; 95% CI 2.00, 2.49). Lipids and insulin resistance/secretion indices were the most studied non-glycemic biochemical markers, with increased triglycerides and insulin resistance generally associated with greater risk of offspring macrosomia or LGA. Studies evaluating other markers had inconsistent findings as to whether they could be used as precision markers. CONCLUSIONS Maternal overweight/obesity is associated with greater risk of offspring macrosomia or LGA in women with GDM. Pregnancy insulin resistance or hypertriglyceridemia may be useful in GDM risk stratification. Future studies examining non-glycemic biochemical, genetic, other -omic, or sociocultural precision markers among women with GDM are warranted.
Collapse
Affiliation(s)
- Ellen C Francis
- Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.
| | - Camille E Powe
- Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA
| | - William L Lowe
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Sara L White
- Department of Women and Children's Health, King's College London, London, UK
| | - Denise M Scholtens
- Department of Preventive Medicine, Division of Biostatistics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Jiaxi Yang
- Global Center for Asian Women's Health (GloW), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Bia-Echo Asia Centre for Reproductive Longevity & Equality (ACRLE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Yeyi Zhu
- Kaiser Permanente Northern California Division of Research, Oakland, CA, USA
| | - Cuilin Zhang
- Global Center for Asian Women's Health (GloW), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Bia-Echo Asia Centre for Reproductive Longevity & Equality (ACRLE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Marie-France Hivert
- Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA
- Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA
| | - Soo Heon Kwak
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Arianne Sweeting
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
| |
Collapse
|
2
|
Barquiel B, Calvo M, Moreno-Domínguez Ó, Martínez-Sánchez N, Muner M, Bedate MF, Delgado M, López S, Hillman N, González N, De la Calle M, Bartha JL. The PREDG study: A randomised controlled trial testing whether an educational intervention can prevent gestational weight gain in women with obesity. Clin Nutr ESPEN 2023; 57:266-271. [PMID: 37739667 DOI: 10.1016/j.clnesp.2023.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 06/24/2023] [Accepted: 07/07/2023] [Indexed: 09/24/2023]
Abstract
OBJECTIVE The PREDG trial was designed to study the influence of an educative program on gestational weight gain in women with pregestational obesity. METHODS Randomized controlled clinical trial (https://www.isrctn.com/ISRCTN61793947) in 169 women with pregestational obesity (BMI ≥30 kg/m2). Women were randomized to participate in a group education program in nutrition and physical activity or conventional follow-up in a specialized Unit of Obesity and Pregnancy. The nutritional intervention was adjusted to prepregnancy BMI and to the physical activity intensity. Quality was based on the Mediterranean diet. Macronutrients were distributed as follows: 50% carbohydrates, 20% protein and 30% fat. Adequate gestational weight gain was defined between 5 and 9 kg (IOM 2009). Mean gestational weight gain was compared between groups by using the T Student test and frequencies of adequate gestational weight gain were compared by using ꓫ2. RESULTS Gestational weight gain was lower in the intervention group: 8 (4-11) vs 9.2 (6-13) kg, p 0.026. Gestational weight gain was below 9 kg in 24 of 39 (61.5%) women of the intervention vs 10 of 41 (24.4%) of the control group (p 0.001). Regarding obstetric complications, there were 15 (8.3%) cases of gestational diabetes with no differences between the groups. There were 14 of 85 (18.2%) cases of gestational hypertension or preeclampsia in the intervention group compared with 26 of 84 (32.5%) in the control group (p 0.040). With reference to neonatal weight, there were 7 of 82 (8.5%) large for gestational age neonates in the intervention group compared with 15 of 79 (19.2%) in the control group (p 0.050). CONCLUSIONS A group-based educative and structured intervention results in an adequate weight gain and lower rates of gestational hypertension, preeclampsia and large for gestational age neonates in pregnant women with obesity.
Collapse
Affiliation(s)
- Beatriz Barquiel
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain.
| | - Mercedes Calvo
- Department of Obstetrics, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - Óscar Moreno-Domínguez
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - Nuria Martínez-Sánchez
- Department of Obstetrics, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - Marta Muner
- Department of Obstetrics, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - María Francisca Bedate
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - María Delgado
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - Silvia López
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - Natalia Hillman
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - Noemí González
- Division of Diabetes, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - María De la Calle
- Department of Obstetrics, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| | - José Luis Bartha
- Department of Obstetrics, Diabetes, Obesity and Pregnancy Unit, La Paz University Hospital, Madrid, Spain
| |
Collapse
|
3
|
Lyu J, Sun Y, Ji Y, Liu N, Zhang S, Lin H, Wang Y, Yang X, Ma S, Han N, Mi Y, Zheng D, Yang Z, Zhang H, Jiang Y, Ma L, Wang H. Optimal Gestational Weight Gain for Women with Gestational Diabetes Mellitus — China, 2011–2021. China CDC Wkly 2023; 5:189-193. [PMID: 37007862 PMCID: PMC10061829 DOI: 10.46234/ccdcw2023.034] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2023] [Accepted: 02/24/2023] [Indexed: 03/06/2023] Open
Abstract
What is already known about this topic? Joint effects of gestational weight gain (GWG) and hyperglycemia on adverse pregnancy outcomes suggest that lower optimal GWG is optimal for women with gestational diabetes mellitus (GDM). However, there is still a lack of guidelines. What is added by this report? Optimal weekly GWG range after diagnosis of GDM for underweight, normal-weight, overweight, and obese women was 0.37-0.56 kg/week, 0.26-0.48 kg/week, 0.19-0.32 kg/week, and 0.12-0.23 kg/week, respectively. What are the implications for public health practice? The findings may be used to inform prenatal counseling regarding optimal gestational weight gain for women with gestational diabetes mellitus, and suggest the need for weight gain management.
Collapse
Affiliation(s)
- Jinlang Lyu
- School of Public Health, Peking University, Beijing Municipality, China
| | - Yin Sun
- Peking Union Medical College Hospital, Beijing Municipality, China
| | - Yuelong Ji
- School of Public Health, Peking University, Beijing Municipality, China
| | - Nana Liu
- Peking Union Medical College Hospital, Beijing Municipality, China
| | - Suhan Zhang
- Peking Union Medical College Hospital, Beijing Municipality, China
| | - Hang Lin
- Peking Union Medical College Hospital, Beijing Municipality, China
| | - Yaxin Wang
- Peking Union Medical College Hospital, Beijing Municipality, China
| | - Xuanjin Yang
- Peking Union Medical College Hospital, Beijing Municipality, China
| | - Shuai Ma
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Municipality, China
| | - Na Han
- Tongzhou Maternal and Child Health Hospital, Beijing Municipality, China
| | - Yang Mi
- Northwest Women’s and Children’s Hospital, Xi'an City, Shaanxi Province, China
| | - Dan Zheng
- Guiyang Maternal and Child Health Hospital, Guiyang City, Guizhou Province, China
| | - Zhifen Yang
- The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China
| | - Hongping Zhang
- Wenzhou People’s Hospital, Wenzhou City, Zhejiang Province, China
| | - Yan Jiang
- People’s Hospital of Dong’e County, Liaocheng City, Shandong Province, China
| | - Liangkun Ma
- Peking Union Medical College Hospital, Beijing Municipality, China
- Liangkun Ma,
| | - Haijun Wang
- School of Public Health, Peking University, Beijing Municipality, China
- Haijun Wang,
| |
Collapse
|
4
|
Xie X, Liu J, Pujol I, López A, Martínez MJ, García-Patterson A, Adelantado JM, Ginovart G, Corcoy R. Inadequate Weight Gain According to the Institute of Medicine 2009 Guidelines in Women with Gestational Diabetes: Frequency, Clinical Predictors, and the Association with Pregnancy Outcomes. J Clin Med 2020; 9:jcm9103343. [PMID: 33080994 PMCID: PMC7603144 DOI: 10.3390/jcm9103343] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Revised: 10/13/2020] [Accepted: 10/14/2020] [Indexed: 12/19/2022] Open
Abstract
Background: In the care of women with gestational diabetes mellitus (GDM), more attention is put on glycemic control than in factors such as gestational weight gain (GWG). We aimed to evaluate the rate of inadequate GWG in women with GDM, its clinical predictors and the association with pregnancy outcomes. Methods: Cohort retrospective analysis. Outcome variables: GWG according to Institute of Medicine 2009 and 18 pregnancy outcomes. Clinical characteristics were considered both as GWG predictors and as covariates in outcome prediction. Statistics: descriptive, multinomial and logistic regression. Results: We assessed 2842 women diagnosed with GDM in the 1985–2011 period. GWG was insufficient (iGWG) in 50.3%, adequate in 31.6% and excessive (eGWG) in 18.1%; length of follow-up for GDM was positively associated with iGWG. Overall pregnancy outcomes were satisfactory. GWG was associated with pregnancy-induced hypertension, preeclampsia, cesarean delivery and birthweight-related outcomes. Essentially, the direction of the association was towards a higher risk with eGWG and lower risk with iGWG (i.e., with Cesarean delivery and excessive growth). Conclusions: In this cohort of women with GDM, inadequate GWG was very common at the expense of iGWG. The associations with pregnancy outcomes were mainly towards a higher risk with eGWG and lower risk with iGWG.
Collapse
Affiliation(s)
- Xinglei Xie
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain; (X.X.); (J.L.)
| | - Jiaming Liu
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain; (X.X.); (J.L.)
| | - Isabel Pujol
- Servei d’Endocrinologia i Nutrició, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (I.P.); (A.L.); (M.J.M.)
| | - Alicia López
- Servei d’Endocrinologia i Nutrició, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (I.P.); (A.L.); (M.J.M.)
| | - María José Martínez
- Servei d’Endocrinologia i Nutrició, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (I.P.); (A.L.); (M.J.M.)
| | | | - Juan M. Adelantado
- Servei de Ginecologia i Obstetricia, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain;
| | - Gemma Ginovart
- Servei de Pediatria, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain;
| | - Rosa Corcoy
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain; (X.X.); (J.L.)
- Servei d’Endocrinologia i Nutrició, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (I.P.); (A.L.); (M.J.M.)
- Institut de Recerca, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain;
- CIBER-BBN, 28029 Madrid, Spain
- Correspondence: ; Tel.: +349-3556-5661
| |
Collapse
|
5
|
Civantos S, Durán M, Flández B, Merino M, Navea C, Guijarro G, Martell N, Monereo S. Factores predictores de diabetes mellitus posparto en pacientes con diabetes gestacional. ENDOCRINOL DIAB NUTR 2019; 66:83-89. [DOI: 10.1016/j.endinu.2018.08.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/21/2018] [Revised: 08/17/2018] [Accepted: 08/23/2018] [Indexed: 01/23/2023]
|
6
|
Zhong N, Wang J. The efficacy of omega-3 fatty acid for gestational diabetes: a meta-analysis of randomized controlled trials. Gynecol Endocrinol 2019; 35:4-9. [PMID: 30324838 DOI: 10.1080/09513590.2018.1480716] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
INTRODUCTION The efficacy of omega-3 fatty acid to treat gestational diabetes remains controversial. We conduct a systematic review and meta-analysis to explore the influence of omega-3 fatty acid versus placebo on gestational diabetes. METHODS We search PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through March 2018 for randomized controlled trials (RCTs) assessing the effect of omega-3 fatty acid versus placebo on gestational diabetes. This meta-analysis is performed using the random-effect model. RESULTS Five RCTs are included in the meta-analysis. Overall, compared with control group for gestational diabetes, omega-3 fatty acid can significantly reduce fasting plasma glucose (FPG) (mean difference (MD) = -4.91; 95% confidence interval (CI) = -8.16 to -1.66; p = .003), homeostatic model of assessment for insulin resistance (HOMA-IR, MD = -0.99; 95% CI = -1.61 to -0.37; p = .002), high sensitivity C-reactive protein (hs-CRP, MD = -1.43; 95% CI = -2.54 to -0.31; p = .01), but has no remarkable influence on preterm delivery (RR = 1.61; 95% CI = 0.36-7.16; p = .53), gestational age (MD = 0.09; 95% CI = -0.01 to 0.20; p = .08), macrosomia (RR = 0.64; 95% CI = 0.26-1.62; p = .3), newborn weight (MD = 3.37; 95% CI = -15.75 to 22.50; p = .73), and 5-min Apgar score (MD = 0; 95% CI = -0.02 to 0.02; p = .92). CONCLUSIONS Omega-3 fatty acids is associated with significantly reduced FPG, HOMA-IR, and hs-CRP in patients with gestational diabetes.
Collapse
Affiliation(s)
- Naer Zhong
- a Orthopaedics Dept.4 , No. 2 Hospital of Ningbo , Zhejiang , China
| | - Jingnan Wang
- a Orthopaedics Dept.4 , No. 2 Hospital of Ningbo , Zhejiang , China
| |
Collapse
|